Cipher Pharmaceuticals Inc. announced that veteran pharmaceutical industry executive Robert D. Tessarolo has been appointed President and Chief Executive Officer of Cipher, effective April 17, 2017. Mr. Tessarolo will also be nominated for election as a director at the Company's next annual general meeting in May 2017. Mr. Tessarolo has 22 years of experience in the pharmaceutical industry spanning business strategy, general management and commercial operations roles across multiple countries and therapeutic areas.

He has demonstrated expertise in leading pharmaceutical organizations through start-up opportunities and turnaround challenges and delivering rapid growth, expansion and value creation. Mr. Tessarolo most recently held the position of Vice President & General Manager with Celgene Corporation, where he was responsible for leading their U.S. Inflammation & Immunology business. Mr. Tessarolo serves on the Board of Directors of Bradmer Pharmaceuticals.